Fernando Joseph Noel, Alba Rebecca Lim, Alba Willy
Section of Endocrinology, Diabetes and Metabolism, Chinese General Hospital and Medical Center, Philippines.
Section of Gastroenterology, Chinese General Hospital and Medical Center, Philippines.
J ASEAN Fed Endocr Soc. 2019;34(2):134-143. doi: 10.15605/jafes.034.02.03. Epub 2019 Nov 10.
This study aims to determine the relationship between the different factors associated with the severity of findings among patients with Type 2 diabetes and fatty liver.
This is a cross-sectional study. Seven hundred four results were electronically retrieved from a diagnostic center. 285 charts of diabetic patients with fatty liver on ultrasound were reviewed. 164 patients with fatty liver on ultrasound and were included in the study. Several factors were analysed in relation to the severity of findings in the study group.
Fifty five point five percent (55.5%) (91/164) had significant fibrosis and cirrhosis. Hepatic steatosis prevalence was 96% (158/164). Diabetes >5 years (OR 1.75), HbA1c >7% (OR 2.25) and high SGPT levels (OR 2.39) were associated with liver fibrosis and cirrhosis. BMI >25 kg/m2 (OR 1.45), triglyceride levels >150 mg/dl (OR 1.31) and HbA1c >7% (OR 1.74) were associated with hepatic steatosis.
Factors associated with the severity of hepatic fibrosis, cirrhosis and steatosis included above normal BMI, disease duration of >5 years, poor glycemic control and elevated levels of ALT, and serum triglycerides.
本研究旨在确定2型糖尿病合并脂肪肝患者中不同因素与检查结果严重程度之间的关系。
这是一项横断面研究。从一个诊断中心电子检索到704份结果。对285例超声检查显示有脂肪肝的糖尿病患者的病历进行了回顾。164例超声检查显示有脂肪肝的患者被纳入研究。分析了与研究组检查结果严重程度相关的几个因素。
55.5%(91/164)有显著纤维化和肝硬化。肝脂肪变性患病率为96%(158/164)。糖尿病病程>5年(比值比1.75)、糖化血红蛋白>7%(比值比2.25)和谷丙转氨酶水平高(比值比2.39)与肝纤维化和肝硬化相关。体重指数>25kg/m²(比值比1.45)、甘油三酯水平>150mg/dl(比值比1.31)和糖化血红蛋白>7%(比值比1.74)与肝脂肪变性相关。
与肝纤维化、肝硬化和脂肪变性严重程度相关的因素包括体重指数高于正常、病程>5年、血糖控制不佳以及谷丙转氨酶和血清甘油三酯水平升高。